Coherence for Health
Innovation for New Medicines for Infectious Diseases
In developing countries, 6 out of 10 people die from infectious diseases. Nearly 1 billion humans suffer from a neglected infectious disease, according to the World Health Organisation. Yet less than 1% of the new drugs placed on the market from 1975 to the turn of the century were developed for these diseases. This book looks at ways of improving the availability of medicines for infectious diseases through strengthened coherence in health, trade, science and technology, development co-operation and finance.
- Click to access:
-
Click to download PDF - 16.70MBPDF
-
Click to Read online and shareREAD
What Are the Problems?
Why Is It in the Economic Interest of OECD Countries to Address these Problems?
This chapter outlines the impact of neglected infectious diseases in developing countries by citing current morbidity and mortality rates, elucidating the economic burden infectious diseases pose, highlighting the problems of lacking pharmaceutical products, explaining the drug research and development/innovation process, and discussing the economics of drug development. The chapter closes with a section on why OECD is interested in neglected and emerging infectious diseases that mainly affect developing countries.
- Click to access:
-
Click to download PDF - 644.72KBPDF
-
Click to Read online and shareREAD